UCB S.A. (UCBJY) Investment Research Dashboard
About UCB S.A. (UCBJY) stock analysis
Get live UCBJY stock price $142.43, comprehensive UCB S.A. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time UCBJY stock data and investment insights.
Loading chart data...
UCB S.A. (UCBJY) Overview
UCB S.A. (UCBJY) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, UCBJY trades at $142.43 with a market capitalization of 54.23B . Over the past 52 weeks, UCBJY has traded between $105.40 and $168.76 , with the current price positioned at approximately 58% of this range . The stock currently trades at a pr...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 54.23B
- Current price: $142.43
- 52-week range: $105.40 - $168.76
- P/E ratio: 27.23
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
UCB S.A. is a biopharmaceutical enterprise dedicated to developing innovative treatments and solutions for individuals living with neurological and immunological diseases. Its primary product, Cimzia, addresses a spectrum of inflammatory TNF-mediated...
Company Information
- CEO
- Jean-Christophe Tellier
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 10117
Contact Information
- Website
- https://www.ucb.com
- Address
- Allée de la Recherche, 60
- Country
- BE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 27.2)
✓ Lower volatility stock (Beta: 0.20) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for UCB S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for UCB S.A.
- ⚠Investors should consider how UCB S.A. fits within their overall portfolio allocation
Market Cap
54.23B
P/E Ratio (TTM)
27.23
Beta
0.20
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare UCBJY with peer companies:
- Price
- $803.19-7.15% (1D)
- Market cap
- 49.95B
- Price
- $77.89-4.97% (1D)
- Market cap
- 37.30B
- Price
- $17.33-4.06% (1D)
- Market cap
- 31.53B
- Price
- $17.84+2.41% (1D)
- Market cap
- 32.46B
- Price
- $4.92-1.31% (1D)
- Market cap
- 43.29B
- Price
- $175.38+13.76% (1D)
- Market cap
- 58.67B
- Price
- $46.70+4.22% (1D)
- Market cap
- 61.75B
- Price
- $688.12+1.88% (1D)
- Market cap
- 48.06B
- Price
- $68.59+0.48% (1D)
- Market cap
- 48.80B
- Price
- $21.56-0.28% (1D)
- Market cap
- 64.33B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.